All analyses regarding biomarkers for AD and neurodegeneration were performed at the Clinical Neurochemistry Laboratory in Mölndal, Sweden, by experienced and board-certified laboratory technicians who were blinded concerning the clinical information. For details, please refer to (Knorr et al. 2022).
The inter-assay coefficient of variability was 8% (sAPPα), 20% (sAPPβ), 2% (Aβ38), 15% (Aβ40), and 13% (Aβ42). The intra-assay coefficient of variability was below 10% for all biomarkers.
Copyright and License information: The Author(s) ©2024 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.